- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03399760
Efficacy of Injectable Platelet Rich Fibrin (i-PRF) in Enhancing Bone Quality
Evaluation the Dento-alveolar Changes After Platelet Rich Fibrin (i-PRF) Injection During Upper Canine Retraction Using Cone-beam Computed Tomography (CBCT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Extraction is a procedure that is currently performed in orthodontics, either in the context of early treatment or for adolescents with severe crowding or protrusion/overjet. The consequences of this ''simple'' procedure may show up many mucosal and osseous complications such as: bone resorption with collapse of the alveolar process, a gingival cleft or gingival recession in the area surrounding the extraction site. Besides the potential esthetic repercussions, these periodontal defects also give rise to a clinical problem with achieving some orthodontic movements, such as complete closure of the space or uprighting a root.
A systematic review evaluating alveolar bone dimension changes of extraction sockets showed a range of width reduction of 2.6-4.6mm, Two-thirds of the loss occurred in the first 3 months, the remodeling of alveolar bone in the extraction site always decreases ridge volume and deforms the ridge configuration which impairs orthodontic movement of the tooth posteriorly.
Endogenously produced biologicals have been tested based on their roles in the turnover of alveolar bone in response to orthodontic tooth movement as well as during wound healing.
From here it has been thought about using a method to enhance bone quality after extraction. The platelet rich fibrin (PRF) has the ability to enhance tissue regeneration, accelerate wound healing and inducing stem cells differentiation through its growth factors (GFs).
PRF characteristics in comparison to platelet rich plasma PRP are:
- its preparation is completely natural and there is no need for thrombin addition so there isn't immune reaction
- it contains stem cells
- it requires one stage centrifugation
- PRF has been reported to gradually release autologous growth factors and expressed stronger and more durable effect on the cellular proliferation and differentiation than PRP in vitro This is the first study in the world that will use i-PRF with Orthodontic treatment, because of its benefits and easiness of using in dental clinic Study sample that consists of 20 patients, Allocation of the sides of intervention (PRF injection) and control sides is made by computer program (Excel).
After ensuring of the patients compliance with the terms and conditions of this study, the purpose and methods of the study will be explained to the patients using Information Sheet. In case of approval to participate, the patients asked to sign the Informed Consent.
Extra & Intra-oral photographs, impressions and clinical examination will be made.
Canine retraction will be initiated after completion of the leveling and alignment phase via closed nickel-titanium coil springs applying 150 g of force per side at the same time 20ml of patients' blood will be withdrawn and centrifuged (700 rpm within 3 minutes) to get 4ml i-PRF. PRF will be injected at the area of the extracted first premolar, The first point place is in the buccal interventional side (supra periosteal injection) and the second point place is in the palatal interventional side(sub periosteal injection). PRF will be injected twice at the beginning and at the middle of the canine retraction.
High resolution CBCT will be taken before the beginning of canine retraction (T0) and after 6 months (T1).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Damascus, Syrian Arab Republic, 00963
- Damascus University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult healthy patients, Male and female, Age range: 15-27 years.
Class II Division 1 malocclusion:
- Mild / moderate skeletal Class II (ANB ≤7)
- Overjet ≤10
- Normal or excessive facial height (Clinically and then cephalometry assessed using these angles : SN-MP , MM , Y axis)
- Mild to moderate crowding ≤ 4
- permanent occlusion.
- Exist all the upper teeth (except third molars).
Good oral and periodontal health:
- Probing depth < 4 mm
- No radiographic evidence of bone loss.
- Gingival index ≤ 1
- Plaque index ≤ 1
Exclusion Criteria:
- Medical problems that affect tooth movement (corticosteroid, NSAIDs, …)
- patients have anti indication for oral surgery ( medical - social - psycho)
- Presence of primary teeth in the maxillary arch
- Missing permanent maxillary teeth (except third molars).
Poor oral hygiene or Current periodontal disease:
- Probing depth ≥ 4 mm
- radiographic evidence of bone loss
- Gingival index > 1
- Plaque index > 1
- Patient had previous orthodontic treatment
- Craniofacial anomalies (cleft lip and palate patients)
- Smokers
- coagulation disorders and patients treated with anticoagulants.
- patients with immunodeficiency disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: i-PRF assisted upper canine retraction
I-PRF assisted upper canine retraction will be performed in one side of patients with Class II Division 1 malocclusion patients requiring therapeutic extraction of the maxillary first premolars
|
i-PRF (injectable platelet rich fibrin) assisted upper canine retraction
upper canine retraction will be performed in one side of patients with Class II Division 1 malocclusion patients requiring therapeutic extraction of the maxillary first premolars
|
|
Experimental: conventional upper canine retraction
Conventional upper canine retraction will be performed in the other side of patients with Class II Division 1 malocclusion patients requiring therapeutic extraction of the maxillary first premolars
|
upper canine retraction will be performed in one side of patients with Class II Division 1 malocclusion patients requiring therapeutic extraction of the maxillary first premolars
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Canine root resorption
Time Frame: After 6 months from the beginning of canine retraction
|
Root length measurement from a reference line between buccal and palatal cemento-enamel junction (CEJ) to apex.
These lines are perpendicular to the long axis of the canine.
The levels of CEJ and root apex were assessed using a combination of axial, sagittal, and coronal images.
|
After 6 months from the beginning of canine retraction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alveolar bone height in the first premolar region
Time Frame: After 6 months from the beginning of canine retraction
|
By measuring the distance between two lines: The first line: the line passing through the distal and mesial cemento-enamel junction of the canine The second line: the line passing through the crest of the alveolus distal to the canine |
After 6 months from the beginning of canine retraction
|
|
Bone density
Time Frame: After 6 months from the beginning of canine retraction
|
By using Hounsfield Unites (Gray Values)
|
After 6 months from the beginning of canine retraction
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Van der Weijden F, Dell'Acqua F, Slot DE. Alveolar bone dimensional changes of post-extraction sockets in humans: a systematic review. J Clin Periodontol. 2009 Dec;36(12):1048-58. doi: 10.1111/j.1600-051X.2009.01482.x.
- Malmgren O, Goldson L, Hill C, Orwin A, Petrini L, Lundberg M. Root resorption after orthodontic treatment of traumatized teeth. Am J Orthod. 1982 Dec;82(6):487-91. doi: 10.1016/0002-9416(82)90317-7.
- Naik B, Karunakar P, Jayadev M, Marshal VR. Role of Platelet rich fibrin in wound healing: A critical review. J Conserv Dent. 2013 Jul;16(4):284-93. doi: 10.4103/0972-0707.114344.
- Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors. 2009 Feb;27(1):63-9. doi: 10.1080/08977190802636713.
- Lund H, Grondahl K, Grondahl HG. Cone beam computed tomography for assessment of root length and marginal bone level during orthodontic treatment. Angle Orthod. 2010 May;80(3):466-73. doi: 10.2319/072909-427.1.
- Zeitounlouian TS, Zeno KG, Brad BA, Haddad RA. Three-dimensional evaluation of the effects of injectable platelet rich fibrin (i-PRF) on alveolar bone and root length during orthodontic treatment: a randomized split mouth trial. BMC Oral Health. 2021 Mar 2;21(1):92. doi: 10.1186/s12903-021-01456-9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UDDS-Ortho-01-2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malocclusion, Angle Class II, Division 1
-
Postgraduate Institute of Dental Sciences RohtakUnknownAngle Class II, Division 1 MalocclusionIndia
-
Postgraduate Institute of Dental Sciences RohtakRecruiting
-
Damascus UniversityCompletedMalocclusion, Angle Class II, Division 1Syria
-
Faculty of Dental Medicine for GirlsCompletedMalocclusion, Angle Class II, Division 1Egypt
-
Hesham Nabil Ali Al-QamhawyAl-Azhar UniversityRecruitingBimaxillary Protrusion | Malocclusion, Angle Class II, Division 1 | Class I MalocclusionEgypt
-
Damascus UniversityCompletedCLASS II DIVISION 1 MALOCCLUSIONSyria
-
Bezmialem Vakif UniversityPEBS DENTAL CLINICRecruitingClass II Div 1 Malocclusion | Class III Malocclusion | Class II Division 2 Malocclusion | Class I MalocclusionTurkey (Türkiye)
-
Vastra Gotaland RegionGöteborg University; Region Halland; Västra GötalandsregionenNot yet recruitingClass II Malocclusion | Class II Malocclusion, Division 1 | OverjetSweden
-
AL YousefKing Abdullah International Medical Research CenterUnknownMalocclusion, Angle Class I | Malocclusion; Angle Class II Division 1Saudi Arabia
-
Alexandria UniversityCompletedMalocclusion, Angle Class II, Division 1Egypt
Clinical Trials on i-PRF
-
Bezmialem Vakif UniversityCompletedCondition | Blood Clot | Periodontoclasia | Gingiva; Injury | Gingiva DisorderTurkey
-
Inonu UniversityCompletedThin Gingiva | Thin Gingival BiotypeTurkey (Türkiye)
-
Saglik Bilimleri UniversitesiCompletedApical Periodontitis | Necrotic Pulp | Mature Teeth | Discoloration of Teeth | Regenerative Endodontic Procedures | PRFTurkey
-
Hams Hamed AbdelrahmanCompletedSocket Preservation | Tooth ExtractionEgypt
-
Yuzuncu Yıl UniversityActive, not recruitingImpacted Third Molar ToothTurkey
-
Sajjad Ahmed ShakirCompleted
-
Hospital of the Ministry of Interior, Kielce, PolandCompletedTemporomandibular Joint Disorders | Temporomandibular Joint PainPoland
-
Ege UniversityCompletedDisc DisorderTurkey
-
Syrian Private UniversityCompletedPeriodontal PocketsSyrian Arab Republic
-
Second Affiliated Hospital, School of Medicine,...RecruitingBone Loss, AlveolarChina